Partners in Care: Redesigning care delivery for the future.

Autor: Grubaugh M; Martha Grubaugh is a research nurse scientist and assistant professor at UCHealth and University of Colorado College of Nursing in Aurora, Colo. Ellen Seymour is the director of clinical strategy at UCHealth in Aurora, Colo. Danielle Schloffman is the director of nursing innovation and outcomes at UCHealth University of Colorado Hospital in Aurora, Colo. Desirea Ulibarri is a nurse manager at UCHealth University of Colorado Hospital in Aurora, Colo. Brian West is the CNO at UCHealth Pikes Peak Regional Hospital in Woodland Park, Colo. Tosha Kieffer is a nurse manager at UCHealth Memorial Hospital Central in Colorado Springs, Colo. Stephanie Elston is an associate nurse manager at UCHealth University of Colorado Hospital in Aurora, Colo. Michelle Kerr is the director of patient care services at UCHealth Greeley Medical Center in Greeley, Colo., Seymour E, Schloffman D, Ulibarri D, West B, Kieffer T, Elston S, Kerr M

Publikováno v: Nursing management [Nurs Manage] 2024 Oct 01; Vol. 55 (10), pp. 15-22. Date of Electronic Publication: 2024 Sep 30.

Stretchable liquid crystal blue phase gels

Autor: Castles, F., Morris, S. M., Hung, J. M. C., Qasim, M. M., Wright, A. D., Nosheen, S., Choi, S. S., Outram, B. I., Elston, S. J., Burgess, C., Hill, L., Wilkinson, T. D., Coles, H. J.

Publikováno v: Nature Mater. 13, 817 (2014)

Liquid crystalline polymers are materials of considerable scientific interest and technological value to society [1-3]. An important subset of such materials exhibit rubber-like elasticity; these can combine the remarkable optical properties of liqui

Externí odkaz: http://arxiv.org/abs/1208.3117

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Autor: Frezza AM; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Leonard H; EHE Rare Cancer Charity, London, United Kingdom., Aggerholm-Pedersen N; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Badalamenti G; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Baili P; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Data Science Unit, Milan, Italy., Baldi GG; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Bauer S; Medical Oncology, University Hospital Essen, Essen, Germany., Bazzurri S; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Benzonelli I; Medical Oncology, Ospedale San Luigi, Orbassano, Italy., Bertuzzi A; Medical Oncology, IRCCS, Humanitas Research Hospital, Rozzano-Milano, Italy., Blay JY; Medical Oncology, Centre Léon Bérard, Lyon, France., Bianchi G; IRCCS Istituto Ortopedico Rizzoli, Clinica Ortopedica e Traumatologica III a Prevalente Indirizzo Oncologico, Bologna, Italy., Bonfarnuzzo S; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Data Science Unit, Milan, Italy., Bouvier C; Medical Oncology, Centre Léon Bérard, Lyon, France., Boye K; Medical Oncology, Oslo University Hospital, Oslo, Norway., Martin Broto J; Medical Oncology, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Brunello A; Istituto Oncologico Veneto IOV-IRCCS, Medical Oncology 1, Padua, Italy., Campanacci D; Orthopaedic Oncology, Careggi University Hospital, Florence, Italy., Casali PG; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Cicala C; Medical Oncology, Hospital Universitari Vall d'Hebron, Spain., Crotti E; Medical Oncology, IRCCS, Humanitas Research Hospital, Rozzano-Milano, Italy., D'Ambrosio L; Medical Oncology, Ospedale San Luigi, Orbassano, Italy., Dei Tos AP; Department of Pathology, Azienda Ospedaliera di Padova, Padua, Italy., Dieckmann N; Medical Oncology, University Hospital Essen, Essen, Germany., Dufresne A; Medical Oncology, Centre Léon Bérard, Lyon, France., Elston S; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Ferraresi V; Sarcomas and Rare Tumors Departmental Unit-IRCCS Regina Elena National Cancer Institute, Rome, Italy., Gabellini S; Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Giani C; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Giannusa V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Gil Sanjines M; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Evaluative Epidemiology Unit, Milan, Italy., Grassani T; Medical Oncology, Università Campus Bio-Medico, Rome, Italy., Gronchi A; Fondazione IRCCS Istituto Nazionale Tumori, Sarcoma Surgery, Milan, Italy., Lasalvia P; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Evaluative Epidemiology Unit, Milan, Italy., Lindskog S; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hindi N; Medical Oncology, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Ingrosso M; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Ivanescu A; EHE Italia, Milan, Italy., Jones R; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Lugowska I; Maria Skłodowska Curie Institute-Oncology Centre, Early Phase Trial Unit, Warsaw, Poland., Ketzer J; Medical Oncology, University Hospital Essen, Essen, Germany., Mariuk-Jarema A; Maria Skłodowska Curie Institute-Oncology Centre, Early Phase Trial Unit, Warsaw, Poland., Mazzocca A; Medical Oncology, Università Campus Bio-Medico, Rome, Italy., Monteleone L; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Morosi C; Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Napolitano A; Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Nardozza F; IRCCS Regina Elena National Cancer Institute, UOSD Clinical Trial Center, Biostatistics and Bioinformatics, Rome, Italy., Neri E; Orthopaedic Oncology, Careggi University Hospital, Florence, Italy., Nilsson M; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Papakonstantinou A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Breast Cancer, Endocrine Tumors and Sarcoma, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Pasquali S; Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Pharmacology Unit, Milan, Italy., Sbaraglia M; Department of Pathology, Azienda Ospedaliera di Padova, Padua, Italy., Scolari F; Orthopaedic Oncology, Careggi University Hospital, Florence, Italy., Szkandera J; Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria., Valverde C; Medical Oncology, Hospital Universitari Vall d'Hebron, Spain., Vincenzi B; Medical Oncology, Università Campus Bio-Medico, Rome, Italy., Vizzaccaro S; Istituto Oncologico Veneto IOV-IRCCS, Medical Oncology 1, Padua, Italy., Zuccheri F; IRCCS Istituto Ortopedico Rizzoli, Clinica Ortopedica e Traumatologica III a Prevalente Indirizzo Oncologico, Bologna, Italy., Stacchiotti S; Fondazione IRCCS Istituto Nazionale Tumori, Medical Oncology 2, Milan, Italy., Trama A; Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Tumori, Evaluative Epidemiology Unit, Milan, Italy.

Publikováno v: PloS one [PLoS One] 2024 Aug 12; Vol. 19 (8), pp. e0308387. Date of Electronic Publication: 2024 Aug 12 (Print Publication: 2024).

Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab.

Autor: Hernando-Calvo A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Departamento de Medicina, Universidad Autonoma de Barcelona (UAB), Barcelona, Spain., Yang SYC; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Vila-Casadesús M; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Han M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Liu ZA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Berman AHK; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Razak AA; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Lo Giacco D; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Abbas-Aghababazadeh F; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Matito J; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Haibe-Kains B; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Department of Computer Science, University of Toronto, Toronto, ON, Canada.; Vector Institute for Artificial Intelligence, Toronto, ON, Canada., Pugh TJ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Bratman SV; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada., Aleshin A; Natera, Austin, TX., Berche R; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Saavedra O; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Garralda E; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Elston S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Ohashi PS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Immunology, University of Toronto, Toronto, ON, Canada., Vivancos A; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Bedard PL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Aug; Vol. 8, pp. e2400100.

Parts-per-billion (ppb) selective iodine sensors leveraging metal–organic framework nanoenvironment

Autor: Babal, AS, Mollick, S, Kamal, W, Elston, S, Castrejón-Pita, AA, Morris, SM, Tan, JC

Publikováno v: Materials Today. 58:91-99

Ultra-sensitive and highly selective iodine gas sensors play a crucial role during the nuclear radiation leak for a timely detection and mitigation of pollution, ensuring the safety of a vast number of operators and subsequent integrity of the facili

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a294461acc987cc9c5acbfde3c9297c
https://doi.org/10.1016/j.mattod.2022.07.001